Abstract
A new analytical method is presented for the determination of non-steroidal acidic antiinflammatory drugs in water samples. These compounds are used as anti-inflammatory,
antipyretic and analgesic drugs in human health care and in veterinary applications. The
analytical procedure involves in situ derivatization of analytes to their methyl esters
with dimethyl sulphate, headspace sampling using solid-phase microextraction
(SPME), and gas chromatography-mass spectrometry (GC-MS). Optimization of
derivatization, pH, ionic strength, extraction time, SPME fibre and extraction
temperature are described. Methyl esters were extracted with a fused-silica fibre coated
with 100 m polydimethylsiloxane. Response was linealy dependent on concentration
in the range 0.1 10.0 ng/mL. Detection limits are achieved at the level of 0.3 2.9
ng/L. Derivatization SPME/GC-MS analysis yielded good precision (RSD between
7.9 and 14.3 %). The method was validated by analysis of spiked matrix samples.
Key words: non-steroidal acidic anti-inflammatory drugs, derivatization, solid-phase
microextraction, gas chromatography-mass spectrometry.
1. Introduction
Pharmaceuticals used for humans and animals have been identified as emerging
environmental pollutants [1-2]. Non-steroidal acidic anti-inflammatory drugs (NSAIDs)
are among the group of pharmaceutical compounds most often used to treat human and
animal illnesses. These compounds are excreted unchanged or as active metabolites in
high percentages and continuously discharged into domestic wastewaters. Incomplete
removal during wastewaters biological treatments
surface waters at concentrations from ng/L to g/L level [ 3-5]. The complete effects on
aquatic organisms and humans are not well understood. Due to their biological activity,
their determination in the environment is important [6].
Suitable methods exist for a quantitative measurement of NSAIDs in water
samples, using gas chromatography-mass spectrometry (GC-MS), high performance
liquid chromatography-mass spectrometry (HPLC-MS), micellar electrokinetic capillary
chromatography (MEKC) and capillary electrophoresis [7-12], but in general the
preconcentration step is extensive, requires large sample volumes
2.0 L), sample clean-up or the use of organic solvents. There is a need for fast and
simple methods to supply these analysis.
Solid phase microextraction (SPME) is a two-step process conducive to the
simultaneous extraction and preconcentration of organic compounds. Since its
introduction, SPME has gained popularity as a simple, solvent-free, reliable and flexible
tool for the sampling of a variety of volatile and semivolatile compounds. SPME
requires less sample volume than solid phase extraction or liquid liquid extraction.
SPME is suitable for analysis of drugs residues in water. On the other hand GC analysis
of acidic drugs is complicated because a derivatization step is necessary prior to
analysis. Generally, prior to the determination of acidic drugs in water, the analytes are
transferred to an organic matrix where derivatization takes place. SPME allows the
derivatization of the analytes to take place in the sample matrix, in the SPME fibre
coating or in the GC injector port [13-16]. However few studies consider the option of
performing the derivatization directly in the water matrix. To date, NSAIDs have not
been investigated by direct derivatization-SPME procedure. By in situ methylation, the
acidic drugs are converted to less polar methyl esters, which may improve the extraction
into the SPME fibre.
In this paper, a new method for analysis of six non steroidal acidic antiinflammatory drugs (ibuprofen, flufenamic acid, naproxen, mefenamic acid, tolfenamic
acid, and meclofenamic acid) in water samples using headspace SPME/GC-MS is
proposed. The analytical procedure involves in situ derivatization of acidic drugs to
their methyl esters with dimethyl sulfate.
2. Experimental
2.1. Materials and reagents
All reagents were of analytical-reagent grade unless stated otherwise. Water was
purified with a Milli-Q plus system (Millipore). Ibuprofen, flufenamic acid, naproxen,
mefenamic acid, tolfenamic acid and meclofenamic acid were supplied by Sigma (St.
Louis, MO, USA). A stock standard soultion of 1000 g/mL of each compound was
prepared in basic Milli-Q water. Working solutions were obtained by appropriated
dilutions with Milli-Q water. The derivatization reagent dimethyl sulfate (DMS) was
purchased from Riedel-de Haen. Tetrabutylammonium hydrogen sulfate (TBA-HSO4) was
obtained from Fluka. A manual fibre holder for SPME was purchased from Supelco
(www.sigma-aldrich.com). Two types of fibre, 100 m polydimethylsiloxane and 85
m polyacrylate were obtained from the same manufacturer and conditioned before use
as recommended by the manufacturer. The Statgraphics software package was used for
the regression analysis (linear model).
2.2. Instrumentation
A Agilent Technologies 6890N GC system equipped with a split-splitless injector
for the HP-5MS fused silica capillary column (30 m x 0.25 mm i.d., 0.25 m film
thickness), and mass spectrometer detector model Agilent Technologies 5973 was used.
A silanized narrow-bore injector liner (0.75 mm id) for the SPME injections was
installed and the fiber was inserted into this injector using the splitless mode with the
split closed for 3 min. The injector temperature was set at 250 C and the transfer line
temperature was 280 C. The oven temperature was held at 50 C for 3 min, then heated
to 250 C at a heating rate of 30 C/min. Temperature was held at 250 C for 4.5 min.
The carrier gas was helium (purity 99.999 %) at a flow rate of 1 mL/min. The mass
spectrometer detector was tuned by maximum sensitivity autotune. The following m/z
values were acquired in the electron impact ionization mode by single ion monitoring
and used for quantification of the analytes: 161- 220 for ibuprofen, 263- 295 for
flufenamic acid, 185-244 for naproxen, 223-255 for mefenamic acid, 208-275 for
tolfenamic acid and 242-309 for meclofenamic acid.
2.3 Procedure
6.0 mL of standard solution or sample was placed in a 14 mL screw-cap glass
vial. Phosphate buffer solution (pH 6.0, 3.0 mol/L, 2.0 mL) and Na2SO4 (2.88 g) were
then added and the sample was agitated with a 1.8 cm long PTFE-coated stir bar. After
addition of the ion-pairing reagent (TBA-HSO4, 7.5x10-4 M, 60 L), the vial was
closed. 15 L of derivatization reagent (DMS) was then injected through the septum
and the vial was immersed in a temperature-controlled oil bath. After 10 min at 65 2
C, the PDMS fibre was exposed to the headspace above the aqueous solution for 45
min. The samples were agitated with a magnetic stirring bar at 500 rpm during both
derivatization and extraction. After the extraction the fibre was directly exposed to the
hot injector of the GC for 5 min and the chromatogram was registered.
Calibration graphs in Milli-Q water were thus constructed using solutions of the
analytes of known concentrations.
3. Results and discussion
3.1. Optimization of the microextraction with in situ derivatization
It has been reported that DMS reacts with haloacetic acids and chlorophenoxy
acid herbicides
and 85 m polyacrylate.
The optimum pH was determined in the range between 3 and 10. As shown in
the Fig. 1, no significant effect was observed in the range of 3 - 7. At higher pH, a
decrease was observed in the response. From these results it was decided to adjust the
pH of water samples to 6.0. A 0.75 M concentration of the phosphate buffer (pH 6.0)
was selected to obtain an adequate buffering capacity.
Figure 1
Figure 3
SPE-derivatization-GC/MS,
SPME-derivatization-GC/MS
or
SPE-
Table 1
The optimum headspace SPME sampling conditions for Milli-Q water were
applied to the tap water and wastewater matrices.
Absolute response was lower with wastewater samples than with Milli-Q water.
This might be due to the presence of additional organic and inorganic compounds that
may interfer with diffusion and volatilization of methyl esters decreasing the
Figure 4
4. Conclusions
A simple and practical GC-MS method in combination with in situ derivatization
headspace SPME for the determination of the non steroidal acidic anti-inflammatory
drugs ibuprofen, flufenamic acid, naproxen, mefenamic acid, tolfenamic acid, and
meclofenamic acid in water samples is presented. Sensitive responses were obtained
using 15 L of DMS, 60 L of TBA-HSO4, a 100 m polydimetilsiloxane fibre, 2.88 g
Na2SO4, 45 min extraction time, pH 6.0 and 65C in combination. Non-equilibrium
conditions were adopted in order to reduce the extraction time. Matrix effects can be
avoided with the use of the standard addition method for quantitation. In view of it
simplicity and sensitivity, the present method is applicable for the quantification of
residues of NSAIDSs studied in tap water and wastewater samples.
Acknowledgements
The authors thank the CONDES-LUZ for providing support for this work.
References
(2004) 891.
[7]
[8] W.C. Lin, H.C. Chen, W.H. Ding, J. Chromatogr. A 1065 (2005) 279.
[9] M. Gros, M. Petrovic, D. Barcel, Talanta 70 (2006) 678.
[10] A. Macia, F. Borrull, C. Aguilar, M. Calull, Electrophoresis 25 (2004) 428.
[11] A. Macia, F. Borrull, M. Callul, C. Aguilar, J. Chromatogr. A 1117 (2006) 234.
[12] S. Weigel, R. Kallenborn, H. Huhnerfuss, J. Chromatogr. A 1023 (2004) 183.
[13] T. Henriksen, B. Svensmark, B. Lindhardt, R. Juhler, Chemosphere 44 (2001)
1531.
[14] I. Rodrguez, J. Carpinteiro, J.B. Quintana, A.M. Carro, R.A. Lorenzo, R. Cela, J.
Chromatogr. A 1024 (2004) 1.
[15] M. del Olmo, A. Zafra, B. Suarez, A. Gonzalez-Casado, J. Taoufiki, J.L. Vilchez, J.
Chromatogr. B 817 (2005) 167.
[16] M. Lee, R. Lee, Y. Lin, C. Chen, B. Hwang, Anal. Chem. 70 (1998) 1963.
10
11
Table 1
Analytical parameters
IBU
FLU
Analytes*
NAP
MEF
TOL
MEC
296,390
-345,102
Intercept (a)
Slope (b)
2.9x106
2.5x106
1.2x106
1.8x106
1.4x106
1.0x106
Correlation coefficient
0.999
0.996
0.998
0.991
0.997
0.994
Linearity
[1 - R.S.D(b)] (%)
Detection limit (ng/L)
99.3
97.6
98.7
97.9
98.6
98.1
0.3
0.4
2.7
1.3
1.6
2.9
Quantification limit
(ng/L)
Repetibility
(R.S.D.,%), n = 8
0.1 ng/mL
1.0
1.4
9.0
4.4
5.4
9.7
13.2
13.9
14.3
14.2
14.1
11.8
1.3 ng/mL
11.4
10.6
11.3
10.0
12.7
10.9
2.5 ng/mL
11.5
10.7
11.4
10.2
12.6
11.2
3.0 ng/mL
7.9
8.9
9.8
9.6
10.2
11.4
*IBU: ibuprofen, FLU: flufenamic acid, NAP: naproxen, MEF: mefenamic acid, TOL:
tolfenamic acid, MEC: meclofenamic acid.
12
Table 2
Results of assays to check the accuracy of the proposed method for NSAIDs in spiked
top water and wastewater samples.
Analyte
Sample
Spiked
Found*
% Recovery
(ng/mL)
(ng/mL)
Ibuprofen
Tap Water
0.09
0.08 0.01
88.9
3.0
2.83 0.33
94.3
Wastewater
0.5
0.38 0.05
76.0
4.0
3.47 0.48
86.8
Flufenamic
Tap Water
0.09
0.12 0.02
133.3
acid
3.0
2.75 0.37
91.6
Wastewater
0.5
0.57 0.09
114.0
4.0
3.46 0.55
86.5
Naproxen
Tap Water
0.09
0.09 0.01
100.0
3.0
3.08 0.41
102.7
Wastewater
0.5
0.48 0.06
96.0
4.0
3.69 0.70
92.3
Mefenamic
Tap Water
0.09
0.07 0.01
77.8
acid
3.0
2.76 0.40
92.0
Wastewater
0.5
0.58 0.11
116.0
4.0
3.63 0.67
90.8
Tolfenamic
Tap Water
0.09
0.08 0.02
88.8
acid
3.0
2.97 0.39
99.0
Wastewater
0.5
0.56 0.12
112.0
4.0
3.46 0.56
86.5
Meclofena
Tap Water
0.09
0.10 0.02
107.5
mic
acid
3.0
2.76 0.32
92.0
Wastewater
0.5
0.41 0.10
82.0
4.0
3.14 0.59
78.5
* Average value standard deviation of five determinations.
"% Recovery" refers to the NSAIDs concentrations determined rather than the actual
percent of analytes extracted by the SPME analysis.
Figures captions
Figure 1. Effect of sample pH for in situ methylation head space SPME of the six
NSAIDs.
13
14
Ibuprofen
Naproxen
Tolfenamic acid
Flufenamic acid
Mefenamic acid
Meclofenamic acid
6,0E+07
Area
4,0E+07
2,0E+07
0,0E+00
3
11
pH
Figure 1
15
Figure 2
16
Flufenamic acid
Mefenamic acid
Meclofenamic acid
1,2E+08
Naproxen
Tolfenamic acid
Ibuprofen
1,5E+07
1,0E+07
4,0E+07
5,0E+06
0,0E+00
0,0E+00
300
Area
8,0E+07
50
100
150
200
250
L of TBA-HSO4 added
Figure 3
17
Figure 4
18